{"name":"Larry J. Siever","slug":"larry-j-siever","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE51ekNmN1BoZEVFSEVpS3l3QkNYT0JGVTQzVTJIbk13aXdUZnJSMHVnTG1tQTNIM1JvNFk3blFfMGlWWXdzUk1HbHlaY3QxZFRkMzhRTE1ubTBQLUtTY0x1aktBVzVUQVVqMHJvSGdvM3RiS3N4VDUzSkhLMA?oc=5","date":"2019-01-18","type":"pipeline","source":"Psychiatry Online","summary":"Guanfacine Augmentation of a Combined Intervention of Computerized Cognitive Remediation Therapy and Social Skills Training for Schizotypal Personality Disorder - Psychiatry Online","headline":"Guanfacine Augmentation of a Combined Intervention of Computerized Cognitive Remediation Therapy and Social Skills Train","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVEFVX3lxTE1GcGtHM0lQZklSQW00VG44VmtoQU9IYkRHLU9tMWxWVmRDTDZ5M3d1S1J6T01Ic0dNX1htQlhCbjI0Q19UYmNJck51aVdKQkhTQU5kaQ?oc=5","date":"2014-07-30","type":"pipeline","source":"nature.com","summary":"Dopamine Receptor Agonist Dihydrexidine (DAR-0100A) on Working Memory in Schizotypal Personality Disorder - nature.com","headline":"Dopamine Receptor Agonist Dihydrexidine (DAR-0100A) on Working Memory in Schizotypal Personality Disorder","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}